Table 4: Individualized application plan for each patient. |
| | Antibiotic | Antipyretic | Arg. m. p. D30 | Echinacea D6 | Ferr. sid. D20 | Millefolium D4 | Ferr. phos. D6 | Equisetum D20 | Petasites D3 | Prunus spi. D3 | Sticta pulm D3 | Tartarus stibiatus D4 | Bryonia D4 | Gelomyrtol | Carb. bet. D20 | Ginger
| Millefol.
| Cochlearia
| Mustard
| Potatoes
|
| Application | | | s. c. | s. c./p. o. | s. c. | s. c. | s. c. | s. c. | p. o. | p. o. | p. o. | s. c. | p. o. | p. o. | s. c. | Ext. | Ext. | Ext. | Ext. | Ext. | Patient Nr | | | | | | | | | | | | | | | | | | | | | 1 | | | + | | | + | | | + | | | | | | + | | + | | | | 2 | | | | + | | + | | | + | | | | | | | + | + | | | | 3 | Pretreated | | + | + | | | | + | + | + | | | | | + | + | + | | | | 4 | | | | | | + | | D15 | + | | | + | + | | + | + | + | | + | | 5 | | | + | + | D10 | D10 | + | | | | D6 | | | | + | | + | | 6 | | | + | + | | + | | D3 Dil. | D6 | | | + | | | + | + | + | | | | 7 | + | | + | + | | + | | | + | + | | | Dil. | | + | + | + | | | | 8 | | | | | D10 | | | | D2 | | | | + | | | + | | | | | 9 | + | + | | | | + | | | | | | | | | | | | | | | 10 | | | | + | | + | + | | D6 | | + | + | + | | + | + | | | | + | 11 | Pretreated | | + | + | | + | | | D6 | | + | | | | + | + | + | | | | 12 | | | | + | | + | | | + | + | + | + | | + | + | | | | + | | 13 | Pretreated | | | | | + | | | | | | | | | | | | | | | 14 | | | + | + | | + | | | D2 and D6 | | + | | | | | + | | | | | 15 | Pretreated | | + | + | | + | | | D6 | + | | | + | | | + | | | | + | 16 | | | + | + | | + | | | + | + | + | | Dil. | + | + | + | + | | | | 17 | | | + | | | + | | | D2 | | | | Dil. | + | + | + | + | | | | 18 | | | D8 | + | | + | | | + | + | | | Dil. | | | | + | | | | 19 | | | | | D10 | | | | + | | | + | | | | | | | | + | 20 | | | | | D10 | + | | | + | | | + | + | | | + | + | | | + | 21 | | | + | + | | + | | | + | | | | | + | + | + | | | | | 22 | | | | + | | + | | | + | + | + | | | | + | + | + | + | | | 23 | | | + | + | | + | + | | + | | + | | + | | + | + | + | + | + | | 24 | | | + | + | | + | | | + | | | | + | | + | + | + | | | | 25 | | | + | + | | + | | | + | + | | | Dil. | | | + | + | | + | | 26 | | | | | + | + | | | + | | | | | | | + | | | + | |
|
|
This table shows the individual therapy plan of each patient. Peroral (p.o.) and subcutaneous medication (s.c.) is outlined as well as external applications (Ext.). We omitted the illustration of convential co-medication. If the applied homeopathic potencies differed from the described in the headline, it was particularly outlined in the table. CAP-study group are bold.
|